Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Carrier-Free Triterpene Prodrug for OSCC
2026-08-14
This ACS Applied Materials & Interfaces study developed a carrier-free, self-assembled prodrug from glycyrrhetinic acid, ginsenoside Rh2, and a ROS-cleavable thioketal linker for oral squamous cell carcinoma therapy. Its central innovation is a self-reinforcing mechanism in which tumor-associated ROS triggers drug release while liberated glycyrrhetinic acid generates additional ROS, strengthening apoptosis and reducing reliance on conventional nanocarriers.
-
Deferiprone: Designing Iron-Stress Assays
2026-08-14
Deferiprone enables controlled investigation of iron-stress phenotypes rather than simple cytotoxicity. This guide translates enterocyte metabolomics into practical assay design for cancer biology, apoptosis, oxidative stress, and translational models.
-
Cyclosporin A: Mechanism, Evidence, and Research Use
2026-08-13
Cyclosporin and Cyclosporin A are cyclophilin-directed immunosuppressive compounds used to study calcineurin–NFAT signaling, T-cell activation, and mitochondrial permeability transition. The strongest mechanistic evidence identifies Cyclophilin A as the principal mediator of cyclosporine-dependent immunosuppression in the tested mouse and T-cell models.
-
FLAG tag Peptide for Myelin Protein Assays
2026-08-13
Learn how the FLAG tag Peptide (DYKDDDDK) can connect recombinant protein detection with mechanistic studies of oligodendrocyte differentiation. This article translates recent NMD–Hnrnpl–Mag findings into practical tag design, purification, elution, and assay-validation decisions.
-
How Kinase Inhibitors Tune p38α Dephosphorylation
2026-08-12
A 2024 bioRxiv study shows that some kinase inhibitors can do more than occupy the p38α active site: they can stabilize an activation-loop conformation that accelerates dephosphorylation by WIP1. Biochemical experiments and X-ray structures establish a conformational mechanism that may guide more specific kinase-inhibitor design, while the preprint does not by itself validate applications in cells, animals, or disease models.
-
FLAG tag Peptide: Exosome Assay Workflows
2026-08-12
Use the FLAG tag Peptide (DYKDDDDK) to purify, detect, and competitively elute tagged proteins under comparatively gentle conditions. This workflow translates the RAB31–flotillin exosome model into practical affinity-capture, interaction, and pathway-dissection assays while clearly separating validated findings from optimization starting points.
-
BMS-777607: A MET Inhibitor for Assay Design
2026-08-11
BMS-777607 is a selective c-Met inhibitor with activity across the MET receptor family. This article distinguishes its role in hiPSC-derived platelet assays from its evidence in cancer metastasis models, emphasizing target attribution, controls, and practical assay design.
-
Adipose-Neural Axis in Cardiac Arrhythmia
2026-08-11
Fan et al. developed a stem cell-based coculture model showing how epicardial adipose tissue can communicate with sympathetic neurons and cardiomyocytes through a leptin–NPY/Y1R pathway. The findings connect adipose-derived signaling to NCX and CaMKII activity, provide mechanistic targets for arrhythmia research, and are supported by clinical observations in atrial fibrillation.
-
DOPE Workflows for Delivery and Fungal Lipid Assays
2026-08-10
DOPE combines endosomal membrane-fusion activity with a practical role in phosphatidylethanolamine rescue assays for fungal developmental biology. This guide connects formulation design, nucleic acid delivery, and Magnaporthe oryzae ferroptosis experiments with executable preparation steps and troubleshooting advice.
-
Nitrocefin Assays: Workflow, Optimization, and Use Cases
2026-08-09
Nitrocefin converts β-lactamase activity into a rapid yellow-to-red signal that supports enzyme characterization, resistance research, and inhibitor screening. This practical guide covers assay setup, kinetic readouts, peptide-inhibitor validation, and troubleshooting for reproducible results.
-
Protoporphyrin IX at the Heme–Ferroptosis Interface
2026-08-08
Protoporphyrin IX is a photodynamic compound that connects heme formation, oxidative stress, and ferroptosis research. This article explains how to interpret its photochemical and iron-related effects alongside the METTL16–SENP3–LTF findings in hepatocellular carcinoma.
-
Nurr1+ Neuron Birth Patterns in the Rat Claustrum
2026-08-07
Fang, Wang, and Naumann establish a developmental map of Nurr1-positive neurons across the rat claustrum, endopiriform region, and lateral cortex. By combining EdU birth dating with Nurr1 in situ hybridization, the study resolves sequential neurogenesis and spatial gradients that clarify how anatomically related domains emerge.
-
CARMIL MB Domain: Mechanisms Regulating Actin Assembly at Me
2026-08-07
The reference study elucidates how the membrane-binding (MB) domain of CARMIL orchestrates actin assembly by dynamically targeting and regulating capping protein (CP) at cellular membranes. These findings provide mechanistic insight into how actin filament capping and uncapping are controlled, resolving longstanding questions about cytoskeletal regulation and offering practical avenues for protein interaction analysis.
-
Mycophenolic Acid: Dehydrogenase Inhibitor in Immune Assays
2026-08-06
Mycophenolic acid is redefining immunometabolism research by enabling precise metabolic modulation during standardized whole-blood stimulation workflows. This article decodes applied protocols, troubleshooting, and the innovative edge of APExBIO’s high-purity compound for robust cytokine profiling.
-
Nystatin (Fungicidin): Antifungal Mechanism, Efficacy & Prot
2026-08-06
Nystatin (Fungicidin) is a polyene antifungal agent that disrupts fungal cell membranes, exhibiting potent inhibition against multiple Candida species. Its efficacy, solubility, and protocol guidance are well-characterized for research use, but Nystatin is not active against all pathogens and has defined stability and usage limits.